+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? Yes



POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? Yes



Chest 154(4): 746-748




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065881344

Download citation: RISBibTeXText

PMID: 30290925

DOI: 10.1016/j.chest.2018.06.022


Related references

A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety 17(5): 509-517, 2018

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA. International Journal of Chronic Obstructive Pulmonary Disease 14: 531-546, 2019

Characteristics and health care resource use of subjects with COPD in the year before initiating LAMA monotherapy or LAMA+LABA combination therapy: A U.S. database study. Managed Care 27(5): 40-47, 2018

Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?. International Journal of Chronic Obstructive Pulmonary Disease 12: 1877-1882, 2017

LAMA/LABA fixed dose combination for treatment of COPD. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(5): 820-826, 2016

LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. European Respiratory Review 26(143):, 2017

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 12: 907-922, 2017

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 13: 3203-3231, 2018

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. International Journal of Chronic Obstructive Pulmonary Disease 10: 1093-1102, 2015

Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes. Primary Care Respiratory Journal 21(1): 101-108, 2012

Comparative Effectiveness and Safety of LABA-LAMA vs LABA-ICS Treatment of COPD in Real-World Clinical Practice. Chest 155(6): 1158-1165, 2019

Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA. Respiratory Medicine 139: 65-71, 2018

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study. Lancet. Respiratory Medicine 6(11): 855-862, 2018

COPD: LAMA / LABA fixed combination more effective than separately. Praxis 105(3): 167-168, 2016

Pharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?. European Clinical Respiratory Journal 2:, 2015